Loading insider details...
Beta
Latest Form 4 (Sep 24, 2026): Sale of 292 TXG shares, $22.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | 10x Genomics, Inc. (TXG) | Sale | 292 | $22.8K |
| Aug 26, 2026 | 10x Genomics, Inc. (TXG) | Sale | 561 | $35.2K |
| Jun 18, 2026 | 10x Genomics, Inc. (TXG) | Sale | 5,359 | $174.6K |
| Jun 8, 2026 | 10x Genomics, Inc. (TXG) | Grant/Award | 8,829 | n/a |
| May 18, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 7,751 | n/a |
| Jun 5, 2025 | 10x Genomics, Inc. (TXG) | Grant/Award | 15,357 | n/a |
| May 19, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 5,740 | n/a |
| Jun 20, 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 5,345 | n/a |
| Jun 13, 2024 | 10x Genomics, Inc. (TXG) | Grant/Award | 8,649 | n/a |
| Jun 16, 2023 | 10x Genomics, Inc. (TXG) | Grant/Award | 1,865 | n/a |